Epkinly [package insert]. Plainsboro, NJ; Genmab, Inc.; May 2024 Compendium) epcoritamab. National Comprehensive Cancer Network
Glofitamab [package insert]. Genetech US, Inc. Epcoritamab [package insert]. Genmab US, Inc.LUNSUMIO [package insert]. Genentech, Inc. Page
Package insert. Hospira; 2024. 19. Cefazolin. Package insert. GSK; 2024. 20. Ceftriaxone. Package insert. Sandoz; 2024. 21. Daptomycin. Package insert
EPKINLY (epcoritamab injection / epcoritamab for injection) Page 5 of 40 PART I: HEALTH PROFESSIONAL INFORMATION 1 INDICATIONS EPKINLY (epcoritamab injection / epcoritamab for injection) is indicated for: the treatment of adult patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL)
by D Scott 2024 Cited by 6(2024). Victoza [package insert]. (2024). Januvia [package insert]. (2024). Onglyza [package insert]. (2024). Precose [package insert]. (2024). Glyset [package
Epkinly [package insert]. Plainsboro, NJ; Genmab US, Inc.; May 2024 Compendium) epcoritamab. National Comprehensive Cancer Network
Epkinly Prescribing Information. Package insert / product label Generic name: epcoritamab-bysp Dosage form: injection, solution Drug class: Bispecific T-cell engagers (BiTE) J Code (medical billing code): J9321 (0.16 mg, injection)
On J, The Food and Drug Administration approved epcoritamab Epkinly [package insert]. Plainsboro, NJ; Genmab US Inc; 2024
epcoritamab-bysp injection, for subcutaneous use (Epkinly) For full prescribing information, please refer to current package insert or other
I would like to know more about this package. ^.^